Anges MG Of Japan Joins With Korean Firm To Develop Oral Hypertension Vaccine
This article was originally published in PharmAsia News
Executive Summary
Japanese biopharmaceutical venture firm Anges MG Inc. and Bioleaders Corp of Korea are joining hands to develop an oral hypertension vaccine.